GlassScriptPhysician profile
Dale J Misiek
NPI 1285608141
$13,205.47
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,466 · 2020: $416 · 2021: $6,113 · 2022: $58.17 · 2023: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $152.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $6,729.66 | 2019-2021 | |
| Straumann USA LLC | $5,674.00 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $200.75 | 2019-2021 | |
| Depuy Synthes Sales INC. | $182.44 | 2021-2023 | Matrixorthognathic, Trumatch, Matrixmidface |
| Biohorizons Implant Systems INC. | $152.48 | 2020-2022 | |
| Terumo Bct, INC. | $105.65 | 2019 | |
| Stryker Corporation | $99.14 | 2021-2023 | Na, Vsp System, Vsp Cranial, Smartlock |
| Geistlich Pharma, North America, INC. | $61.35 | 2020-2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Misiek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.